Biotechnology company Cyon Therapeutics announced on Tuesday the execution of a license agreement with Novartis AG
(NYSE:NVS) for its anti-PCSK9 antibody, LGT-209.
Assess the growth potential of Novartis AG
in its therapy areas of focus
Contact: John Gilardi, Novartis AG
- Phone: +41 61 324 3018, Web site: www.
7bn) acquisition of the vaccine unit of Swiss peer Novartis AG
, Basel, Switzerland, has purchased a stake worth 4.
19 August 2014 - Swiss pharma major Novartis AG
(VTX:NOVN) is to invest in Israeli cancer therapies developer Gamida Cell Ltd through a deal potentially worth up to USD635m (EUR475m).
New York) settled a lawsuit against Switzerland's Novartis AG
for alleged infringement of a U.
17 July 2014 - German investment firm BWK GmbH announced today the sale of its 24% stake in LTS Lohmann Therapie-Systeme AG, adding that co-investor Novartis AG
(VTX:NOVN) is also selling its interest in the German medical patches supplier.
UK healthcare group GlaxoSmithKline plc (LON:GSK) said its deal to exchange assets and create a joint venture with Swiss peer Novartis AG
(VTX:NOVN) steps up its strategy for sustainable, broadly sourced sales growth and increased long-term earnings.